HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Clinical trials for HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive 'Smart Bomb' targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new radioactive drug that seeks out a protein called Nectin-4 on cancer cells. It is for people with advanced solid tumors (like bladder, breast, lung, or cervical cancer) that have not responded to prior treatments. The main goals are to find a saf…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New PET tracer aims to light up Hard-to-Find breast cancer spots
Diagnosis Recruiting nowThis early-phase study tests a new radioactive imaging agent called 68Ga-R10602 to see if it can find tumors in people with hormone receptor-positive breast cancer that has spread or come back. About 36 adults whose cancer no longer responds to hormone therapy will receive the ag…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated May 07, 2026 18:40 UTC